Skip to Content
Merck
CN

AB15620

Anti-Olig1 Antibody

Chemicon®, from rabbit

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
ICC, IHC, IP, WB
Citations:
6
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

purified antibody

antibody product type

primary antibodies

clone

polyclonal

species reactivity

rat, mouse

manufacturer/tradename

Chemicon®

technique(s)

immunocytochemistry: suitable, immunohistochemistry: suitable, immunoprecipitation (IP): suitable, western blot: suitable

NCBI accession no.

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

rat ... Olig1(60394)

General description

27 kDa

Immunogen

Recombinant Olig-1.

Application

Detect the Olig1 protein using this Anti-Olig1 validated for use in IP, WB, ICC & IHC.
Research Category
Neuroscience
Research Sub Category
Neuronal & Glial Markers
Western blot: 1:2,500-1:5,000 on rat and mouse.
Immunohistochemistry: 1:1,000-1:5,000
Immunocytochemistry: 1:1,000-1:5,000
Immunoprecipitation: 1:50-1:100

Optimal working dilutions must be determined by the end user.

Biochem/physiol Actions

Olig-1. Recognizes the ~27 kDa Olig-1 protein by Western blot.

Physical form

Format: Purified
Liquid in 100 mM Glycine, 200 mM Tris, pH 8.0.

Preparation Note

Maintain at 2-8°C in undiluted aliquots for up to 6 months after date of receipt.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


Still not finding the right product?

Explore all of our products under Anti-Olig1 Antibody

or

Try our Product Selector Tool to narrow your options


Storage Class

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Shen Li et al.
Brain : a journal of neurology, 142(11), 3456-3472 (2019-09-19)
The immunological barrier currently precludes the clinical utilization of allogeneic stem cells. Although glial-restricted progenitors have become attractive candidates to treat a wide variety of neurological diseases, their survival in immunocompetent recipients is limited. In this study, we adopted a
Activation of developmental nuclear fibroblast growth factor receptor 1 signaling and neurogenesis in adult brain by ?7 nicotinic receptor agonist.
Narla, ST; Klejbor, I; Birkaya, B; Lee, YW; Morys, J; Stachowiak, EK; Prokop et al.
Stem Cells Translational Medicine null
Olga Elsesser et al.
Nucleic acids research, 47(12), 6208-6224 (2019-05-14)
Differentiating oligodendrocytes generate myelin to ensure rapid saltatory conduction in the vertebrate central nervous system. Although oligodendroglial differentiation and myelination are accompanied by dramatic chromatin reorganizations, previously studied chromatin remodelers had only limited direct effects on the process. To study



Global Trade Item Number

SKUGTIN
AB1562004053252470387